Biotech Investors & VC Firms in United States

564 firms in this list, with a median first check of $500K. 46 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Quan Capital 6 people	Grand Cayman	CN	Seed–Late Stage	—	+ Add to CRM
Redmont Capital 3 people	Birmingham	US	Growth	$1M – $10M	+ Add to CRM
Rex Health Ventures 3 people	Raleigh	US	Seed–Series B	$250K – $500K	+ Add to CRM
RMGP Biopharma Investment Fund 6 people	Herzliya	IL	Seed–Series A	—	+ Add to CRM
RTW Investments L.P. 6 people	New York	US	Seed–Series A	—	+ Add to CRM
Scion Life Sciences 6 people	New York	US	Seed–Late Stage	—	+ Add to CRM
Seido Capital 3 people	Brussels	CA	Pre-Seed–Series B	$270K – $2.7M	+ Add to CRM
Shepherd Ventures 3 people	San Diego	US	Series A–Late Stage	$750K – $3M	+ Add to CRM
Soul Ventures 6 people	—	US	Series C–Late Stage	—	+ Add to CRM
Sound Bioventures 6 people	Malmö	SE	Seed–Late Stage	—	+ Add to CRM
Vento 3 people	Torino	IT	Pre-Seed–Seed	$162K – $1.1M	+ Add to CRM
LDV Partners 5 people	Palo Alto	US	Seed–Late Stage	—	+ Add to CRM
SBI Investment 1 person	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
Ahren Innovation Capital 5 people	London	GB	Seed–Late Stage	—	+ Add to CRM
Ennovation Ventures 5 people	Shanghai	CN	Seed–Series B	—	+ Add to CRM
Entrada Ventures 5 people	Santa Barbara	US	Pre-Seed–Series B	—	+ Add to CRM
Fine Structures Ventures 5 people	Boston	US	Seed–Series A	—	+ Add to CRM
Gefen Capital 5 people	Herzliya Pituach	IL	Seed–Series B	—	+ Add to CRM
Global BioAccess Fund 5 people	New York	US	Series A–Late Stage	$10M	+ Add to CRM
J2 Ventures 5 people	Boston	US	Pre-Seed–Series A	—	+ Add to CRM
Level One Fund 5 people	Miami	US	Seed–Late Stage	—	+ Add to CRM
LYZZ Capital 5 people	Shanghai	CN	Seed–Series A	—	+ Add to CRM
Muirwoods Ventures 5 people	Seoul	US	Seed–Late Stage	—	+ Add to CRM
New North Ventures 5 people	Manchester	US	Seed–Series A	—	+ Add to CRM